EUVIMEDEUVIMED entdecken
Crossref

Amalaki rasayana and max HB in sickle cell anaemia: An open label non-comparative clinical trial

Amit Nampalliwar

Bioinformation · 31.10.2026 · 22 (10) · 7409-7414

DOI: 10.6026/973206300227409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Amit Nampalliwar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell anaemia is an inherited hemoglobin disorder characterized by sickling of red blood cells, leading to vaso-occlusion, chronic anaemia and recurrent systemic complications. Therefore, it is of interest to evaluate the clinical efficacy of Amalaki Rasayana and Capsule Max HB in the management of sickle cell anaemia. An open-label, non-comparative clinical trial was conducted on 25 patients at Government Ayurveda College and Hospital, Bilaspur, Chhattisgarh, with outcomes assessed over 60 days using the Dutch-AIMS2-HFF Symptoms Severity Scale, Wilcoxon Signed Rank Test and paired t-test. Treatment produced significant improvements in subjective symptoms, including anaemia (35.71%), pallor (43.40%), bodyache (37.50%), palpitation (43.86%), hand-foot syndrome (25.58%), loss of appetite (41.18%) and recurrent respiratory infection (37.78%), with an overall improvement of 37.86%, alongside increases in Hb, RBC, MCH, MCV and MCHC. Thus, combined Amalaki Rasayana and Capsule Max HB therapy showed clinically meaningful improvement in symptomatic and hematological parameters, supporting its potential as an adjunctive Ayurvedic intervention for sickle cell anaemia.

Zitieren

APA

Nampalliwar, A. (2026). Amalaki rasayana and max HB in sickle cell anaemia: An open label non-comparative clinical trial. Bioinformation, 22(10), 7409-7414. https://doi.org/10.6026/973206300227409

Vancouver

Nampalliwar A. Amalaki rasayana and max HB in sickle cell anaemia: An open label non-comparative clinical trial. Bioinformation. 2026;22(10):7409-7414. doi:10.6026/973206300227409

BibTeX
@article{Nampalliwar2026,
  author = {Nampalliwar, Amit},
  title = {Amalaki rasayana and max HB in sickle cell anaemia: An open label non-comparative clinical trial},
  journal = {Bioinformation},
  year = {2026},
  volume = {22},
  number = {10},
  pages = {7409--7414},
  doi = {10.6026/973206300227409}
}
Kostenlos starten →